|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Clinical Investigation |
1 Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands; 2 Department of Radiology, Emory University School of Medicine, Atlanta, Georgia; 3 Department of Nuclear Medicine, Leiden University Medical Center, Leiden, The Netherlands; and 4 The Interuniversity Cardiology Institute of The Netherlands, Utrecht, The Netherlands
Correspondence: For correspondence or reprints contact: Jeroen J. Bax, MD, PhD, Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. E-mail: jbax{at}knoware.nl
Cardiac resynchronization therapy (CRT) is now a well-recognized therapeutic option for patients with end-stage heart failure. However, not all patients respond to CRT, and, therefore, preimplantation identification of responders is desirable. The aim of the present study was to investigate whether the degree of left ventricular (LV) dyssynchrony, as assessed with phase analysis from gated myocardial perfusion SPECT (GMPS), can predict which patients will respond to CRT. Methods: Forty-two patients with severe heart failure, depressed LV ejection fraction, and wide QRS complex were prospectively included for implantation of a CRT device and underwent GMPS and 2-dimensional echocardiography as part of the clinical protocol. Clinical status was evaluated using the New York Heart Association (NYHA) classification, 6-min walk test, and quality-of-life score. The histogram bandwidth and phase SD (parameters indicating LV dyssynchrony) were assessed from GMPS, and the clinical status and echocardiographic variables were reassessed at 6-mo follow-up. Results: Responders (71%) and nonresponders (29%) had comparable baseline characteristics, except for histogram bandwidth (175° ± 63° vs. 117° ± 51° [P < 0.01]) and phase SD (56.3° ± 19.9° vs. 37°.1 ± 14.4° [P < 0.01]), which were significantly larger in responders compared with nonresponders. Moreover, receiver-operating-characteristic curve analysis demonstrated an optimal cutoff value of 135° for histogram bandwidth (sensitivity and specificity of 70%) and of 43° for phase SD (sensitivity and specificity of 74%) for the prediction of response to CRT. Conclusion: Response to CRT is related to the presence of LV dyssynchrony assessed by phase analysis with GMPS. A cutoff value of 135° for histogram bandwidth and of 43° for phase SD could be used to predict response to CRT. Larger prospective studies are warranted to confirm the present findings.
Key Words: left ventricular dyssynchrony cardiac resynchronization therapy SPECT heart failure
COPYRIGHT © 2007 by the Society of Nuclear Medicine, Inc.
Related articles in JNM:
This article has been cited by other articles:
![]() |
R. J. Gibbons, P. A. Araoz, and E. E. Williamson The Year in Cardiac Imaging J. Am. Coll. Cardiol., January 6, 2009; 53(1): 54 - 70. [Full Text] [PDF] |
||||
![]() |
S. D. Van Kriekinge, H. Nishina, M. Ohba, D. S. Berman, and G. Germano Automatic Global and Regional Phase Analysis from Gated Myocardial Perfusion SPECT Imaging: Application to the Characterization of Ventricular Contraction in Patients with Left Bundle Branch Block J. Nucl. Med., November 1, 2008; 49(11): 1790 - 1797. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chen, J. J. Bax, M. M. Henneman, M. J. Boogers, and E. V. Garcia Is nuclear imaging a viable alternative technique to assess dyssynchrony? Europace, November 1, 2008; 10(suppl_3): iii101 - iii105. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Z. Song Can LV Dyssynchrony as Assessed with Phase Analysis on Gated Myocardial Perfusion SPECT Preferably Predict Response to CRT? J. Nucl. Med., April 1, 2008; 49(4): 686 - 686. [Full Text] [PDF] |
||||
![]() |
M. M. Henneman, J. J. Bax, J. Chen, and E. V. Garcia Reply: Can LV Dyssynchrony as Assessed with Phase Analysis on Gated Myocardial Perfusion SPECT Preferably Predict Response to CRT? J. Nucl. Med., April 1, 2008; 49(4): 686 - 686. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |